These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 15028021)

  • 1. Prognostic value of apoptosis and apoptosis-associated proteins in salivary gland adenoid cystic carcinoma.
    Jia L; Esguerra RL; Tang X; Yin H; Sakamoto K; Okada N; Takagi M
    Pathol Int; 2004 Apr; 54(4):217-23. PubMed ID: 15028021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apoptosis-induced and -suppressed cells in salivary gland adenoid cystic carcinoma: correlation with histological growth patterns.
    Fujita S; Shibata Y; Takahashi H; Tsuda N
    Oral Dis; 1999 Apr; 5(2):117-22. PubMed ID: 10522207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MDM2, P53, P21WAF1 and pAKT protein levels in genesis and behaviour of adenoid cystic carcinoma.
    de Lima Mde D; Marques YM; Alves Sde M; Freitas VM; Soares FA; de Araújo VC; Pinto Ddos S; Mantesso A
    Cancer Epidemiol; 2009 Aug; 33(2):142-6. PubMed ID: 19679062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ataxia-Telangiectasia-Mutated Protein Expression as a Prognostic Marker in Adenoid Cystic Carcinoma of the Salivary Glands.
    Bazarsad S; Kim JY; Zhang X; Kim KY; Lee DY; Ryu MH; Kim J
    Yonsei Med J; 2018 Aug; 59(6):717-726. PubMed ID: 29978608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of p53 immunohistochemical expression in adenoid cystic carcinoma of the salivary glands: a meta-analysis.
    Li Q; Huang P; Zheng C; Wang J; Ge M
    Oncotarget; 2017 Apr; 8(17):29458-29473. PubMed ID: 28206977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic value of spontaneous apoptosis, Bax, Bcl-2, and p53 in oral squamous cell carcinoma of the tongue.
    Xie X; Clausen OP; De Angelis P; Boysen M
    Cancer; 1999 Sep; 86(6):913-20. PubMed ID: 10491515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apoptosis and apoptotic-related factors in mucoepidermoid carcinoma of the oral minor salivary glands.
    Yin HF; Okada N; Takagi M
    Pathol Int; 2000 Aug; 50(8):603-9. PubMed ID: 10972857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic role of apoptotic, Bcl-2, c-erbB-2 and p53 tumor markers in salivary gland malignancies.
    Nagler RM; Kerner H; Ben-Eliezer S; Minkov I; Ben-Itzhak O
    Oncology; 2003; 64(4):389-98. PubMed ID: 12759537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes of histological and biological features by serial passages in a human adenoid cystic carcinoma line transplantable in nude mice.
    Hashitani S; Noguchi K; Manno Y; Moridera K; Takaoka K; Nishimura N; Kishimoto H; Sakurai K; Urade M
    Oncol Rep; 2005 Apr; 13(4):607-12. PubMed ID: 15756431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Protein expression of p53, bcl-2, and bax in adenoid cystic carcinoma of lacrimal gland].
    You JQ; Wang P
    Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(28):1978-82. PubMed ID: 19062739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Basal cell adenocarcinoma of the salivary glands: comparison with basal cell adenoma through assessment of cell proliferation, apoptosis, and expression of p53 and bcl-2.
    Nagao T; Sugano I; Ishida Y; Hasegawa M; Matsuzaki O; Konno A; Kondo Y; Nagao K
    Cancer; 1998 Feb; 82(3):439-47. PubMed ID: 9452259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TUNEL - an efficient prognosis predictor of salivary malignancies.
    Ben-Izhak O; Laster Z; Araidy S; Nagler RM
    Br J Cancer; 2007 Apr; 96(7):1101-6. PubMed ID: 17325701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of apoptosis-related factors p53, Mdm2, and Bcl-2 in advanced ovarian cancer.
    Baekelandt M; Kristensen GB; Nesland JM; Tropé CG; Holm R
    J Clin Oncol; 1999 Jul; 17(7):2061. PubMed ID: 10561259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of mdm2 and p53 expression in bladder cancer. A comparison with cell proliferation and apoptosis.
    Shiina H; Igawa M; Shigeno K; Yamasaki Y; Urakami S; Yoneda T; Wada Y; Honda S; Nagasaki M
    Oncology; 1999 Apr; 56(3):239-47. PubMed ID: 10202280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High expression of Polycomb group protein EZH2 predicts poor survival in salivary gland adenoid cystic carcinoma.
    Vékony H; Raaphorst FM; Otte AP; van Lohuizen M; Leemans CR; van der Waal I; Bloemena E
    J Clin Pathol; 2008 Jun; 61(6):744-9. PubMed ID: 18326020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis and significance of c-MET expression in adenoid cystic carcinoma of the salivary gland.
    Bell D; Ferrarotto R; Fox MD; Roberts D; Hanna EY; Weber RS; El-Naggar AK
    Cancer Biol Ther; 2015; 16(6):834-8. PubMed ID: 25923130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of apoptotic index in non-small cell lung cancer: correlation with p53, mdm2, pRb and p21WAF1/CIP1 protein expression.
    Dworakowska D; Jassem E; Jassem J; Karmoliński A; Dworakowski R; Wirth T; Gruchała M; Rynkiewicz A; Skokowski J; Yla-Herttuala S; Jaśkiewicz K; Czestochowska E
    J Cancer Res Clin Oncol; 2005 Sep; 131(9):617-23. PubMed ID: 16028106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of apoptosis in breast cancer (pT1-pT2). A TUNEL, p53, bcl-2, bag-1 and Bax immunohistochemical study.
    Sirvent JJ; Aguilar MC; Olona M; Pelegrí A; Blázquez S; Gutiérrez C
    Histol Histopathol; 2004 Jul; 19(3):759-70. PubMed ID: 15168338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic impact of molecular analyses in adenoid cystic carcinomas of the salivary gland.
    Preisegger KH; Beham A; Kopp S; Jessernigg G; Gugl A; Stammberger H
    Onkologie; 2001 Jun; 24(3):273-7. PubMed ID: 11455221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of inhibitors of apoptosis proteins in salivary gland adenoid cystic carcinoma: XIAP is an independent marker of impaired cause-specific survival.
    Schnoell J; Kadletz L; Jank BJ; Oberndorfer F; Brkic FF; Gurnhofer E; Cede J; Seemann R; Kenner L; Heiduschka G
    Clin Otolaryngol; 2020 May; 45(3):364-369. PubMed ID: 31984681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.